Cronos Group Inc. (CRON)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$2.68
-2.18%
Mkt Cap $1.00B
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$2.30
Range $2.30 – $2.30
Implied Upside
-14.2%
Consensus $2.30 vs current $2.68